Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

被引:353
|
作者
Hauser, David N. [1 ,2 ]
Hastings, Teresa G. [3 ,4 ,5 ]
机构
[1] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
[2] Brown Univ, NIH, Grad Partnership Program, Dept Neurosci, Providence, RI 02912 USA
[3] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[5] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA
关键词
Parkinson's disease; Mitochondria; Oxidative stress; Dopamine oxidation; RAT-BRAIN MITOCHONDRIA; COMPLEX-I DEFICIENCY; RESOLUTION CRYSTAL-STRUCTURE; CYSTEINE-SULFINIC ACID; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; DOPAMINERGIC-NEURONS; DJ-1-DEFICIENT MICE; DNA DELETIONS; FAMILIAL PARKINSONISM;
D O I
10.1016/j.nbd.2012.10.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The pathogenic mechanisms that underlie Parkinson's disease remain unknown. Here, we review evidence from both sporadic and genetic forms of Parkinson's disease that implicate both mitochondria and oxidative stress as central players in disease pathogenesis. A systemic deficiency in complex I of the mitochondrial electron transport chain is evident in many patients with the disease. Oxidative stress caused by reactive metabolites of dopamine and alterations in the levels of iron and glutathione in the substantia nigra accompany this mitochondrial dysfunction. Recent evidence from studies on the genetic forms of parkinsonism with particular stress on DJ-1, parkin, and PINK-1 also suggest the involvement of mitochondria and oxidative stress. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [31] Mitochondrial Dysfunction in Parkinson's Disease: A Contribution to Cognitive Impairment?
    Scorziello, Antonella
    Sirabella, Rossana
    Sisalli, Maria Jose
    Tufano, Michele
    Giaccio, Lucia
    D'Apolito, Elena
    Castellano, Lorenzo
    Annunziato, Lucio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [32] Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies
    Moradi Vastegani, Sadegh
    Nasrolahi, Ava
    Ghaderi, Shahab
    Belali, Rafie
    Rashno, Masome
    Farzaneh, Maryam
    Khoshnam, Seyed Esmaeil
    NEUROCHEMICAL RESEARCH, 2023, 48 (08) : 2285 - 2308
  • [33] Unraveling the role of Nrf2 in dopaminergic neurons: a review of oxidative stress and mitochondrial dysfunction in Parkinson's disease
    Kaur, Manpreet
    Aran, Khadga Raj
    METABOLIC BRAIN DISEASE, 2025, 40 (02)
  • [34] Mitochondrial dysfunction and oxidative damage in the molecular pathology of Parkinson’s disease
    M. I. Shadrina
    P. A. Slominsky
    Molecular Biology, 2008, 42
  • [35] Mitochondrial Dysfunction and Oxidative Damage in the Molecular Pathology of Parkinson's Disease
    Shadrina, M. I.
    Slominsky, P. A.
    MOLECULAR BIOLOGY, 2008, 42 (05) : 720 - 728
  • [36] Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
    Yan, Michael H.
    Wang, Xinglong
    Zhu, Xiongwei
    FREE RADICAL BIOLOGY AND MEDICINE, 2013, 62 : 90 - 101
  • [37] Oxidative stress and cellular pathologies in Parkinson’s disease
    Lesly Puspita
    Sun Young Chung
    Jae-won Shim
    Molecular Brain, 10
  • [38] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson Disease
    Dolgacheva, L. P.
    Fedotova, E. I.
    Abramov, A. Y.
    Berezhnov, A. V.
    BIOLOGICHESKIE MEMBRANY, 2017, 34 (05): : 4 - 14
  • [39] Mitochondrial control of cell bioenergetics in Parkinson's disease
    Requejo-Aguilar, Raquel
    Bolanos, Juan P.
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 100 : 123 - 137
  • [40] Mitochondrial Dysfunction in Parkinson's Disease: Focus on Mitochondrial DNA
    Buneeva, Olga
    Fedchenko, Valerii
    Kopylov, Arthur
    Medvedev, Alexei
    BIOMEDICINES, 2020, 8 (12) : 1 - 22